Resources
74 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 2/25/2020 (updated 3/28/2024)
A guide to provide the addiction treatment and recovering community with practical information and tools to enhance their capacity to engage in effective stigma reduction efforts.
Posted 2/10/2020 (updated 3/28/2024)
ONDCP released a new tool to assist rural community leaders in building an effective local response to the crisis of addiction, the Rural Community Action Guide: Building Stronger, Healthy Drug-Free Rural Communities. The Guide also has a companion supplement, a listing of promising practices, included.
Posted 12/3/2019 (updated 3/28/2024)
The CHARM or “CHildren And Recovering Mothers” Collaborative is a group of providers from in and around Waldo County, Maine, who are serving mothers and families dealing with pregnancy that is affected by substance use.
Posted 11/27/2019 (updated 3/28/2024)
Negative language and stigma regarding substance use disorder and addiction have shown to be a key barrier to seeking and receiving treatment for people who use drugs.
Posted 6/15/2020 (updated 3/28/2024)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Posted 6/12/2020 (updated 3/28/2024)
Mother & Baby Substance Exposure Toolkit Best Practices All Best Practices came as a part of the California Medication Assisted Treatment Expansion Project
Posted 8/24/2020 (updated 3/28/2024)
Lessons Learned From Listening Sessions With Five Tribes in Minnesota.
Posted 4/16/2020 (updated 3/28/2024)
Stigma keeps people from the best possible care. Beyond Labels is a free Anti-Stigma Toolkit for Women & Babies toolkit from the March of Dimes and RTI International.
Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017
Posted 4/10/2020 (updated 3/28/2024)
Prevalence of respiratory-depressing drugs in opioid overdose deaths is common and increasing and represents a potential target for policy and practice efforts to reduce opioid-related harms.
Posted 8/24/2020 (updated 3/28/2024)
Medications for opioid use disorder, including buprenorphine hydrochloride and methadone hydrochloride, are highly effective at improving outcomes for individuals with the disorder. For pregnant women, use of these medications also improves pregnancy outcomes, including the risk of preterm birth. Despite the known benefits of medications for opioid use disorder, many pregnant and nonpregnant women with the disorder are not receiving them.